Yikon Genomics

MALBACTM technology has overwhelming superiority over other WGA methods with good uniformity, high reproducibility, >90% genome coverage and < 10% allele dropout rate, which makes point mutation and copy number variation study in DNA at single cell level unprecedentedly practicable. Based on MALBACTM technology, Yikon has made single cell sequencing applied to clinical validations, such as embryo pre-implantation genetic screening/diagnosis (PGS/PGD) as well as circulating tumor cell (CTCs) monitoring.

12 36 72
  • Yikon Genomics
    Whole Genome Amplification for Single Cell(s), Picogram to Sub-nanogram Quant...
    from 409.00 EUR